Gut Microbiota Ecological and Functional Modulation in Post-Stroke Recovery Patients: An Italian Study.

SCFAs fecal zonulin gut microbiota ecology gut–brain axis ischemic stroke tryptophan derivatives

Journal

Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893

Informations de publication

Date de publication:
25 Dec 2023
Historique:
received: 27 10 2023
revised: 20 12 2023
accepted: 22 12 2023
medline: 23 1 2024
pubmed: 23 1 2024
entrez: 23 1 2024
Statut: epublish

Résumé

Ischemic stroke (IS) can be caused by perturbations of the gut-brain axis. An imbalance in the gut microbiota (GM), or dysbiosis, may be linked to several IS risk factors and can influence the brain through the production of different metabolites, such as short-chain fatty acids (SCFAs), indole and derivatives. This study examines ecological changes in the GM and its metabolic activities after stroke. Fecal samples of 10 IS patients were compared to 21 healthy controls (CTRLs). GM ecological profiles were generated via 16S rRNA taxonomy as functional profiles using metabolomics analysis performed with a gas chromatograph coupled to a mass spectrometer (GC-MS). Additionally fecal zonulin, a marker of gut permeability, was measured using an enzyme-linked immuno assay (ELISA). Data were analyzed using univariate and multivariate statistical analyses and correlated with clinical features and biochemical variables using correlation and nonparametric tests. Metabolomic analyses, carried out on a subject subgroup, revealed a high concentration of fecal metabolites, such as SCFAs, in the GM of IS patients, which was corroborated by the enrichment of SCFA-producing bacterial genera such as

Identifiants

pubmed: 38257864
pii: microorganisms12010037
doi: 10.3390/microorganisms12010037
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Riccardo Marsiglia (R)

Immunology, Rheumatology and Infectious Diseases Research Area, Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.

Chiara Marangelo (C)

Immunology, Rheumatology and Infectious Diseases Research Area, Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.

Pamela Vernocchi (P)

Immunology, Rheumatology and Infectious Diseases Research Area, Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.

Matteo Scanu (M)

Immunology, Rheumatology and Infectious Diseases Research Area, Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.

Stefania Pane (S)

Unit of Microbiomics, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.

Alessandra Russo (A)

Unit of Microbiomics, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.

Eleonora Guanziroli (E)

Villa Beretta Rehabilitation Center, Valduce Hospital Como, 23845 Costa Masnaga, Italy.

Federica Del Chierico (F)

Immunology, Rheumatology and Infectious Diseases Research Area, Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.

Massimiliano Valeriani (M)

Developmental Neurology, Bambino Gesù Children Hospital, IRCCS, 00165 Rome, Italy.
Center for Sensory Motor Interaction, Aalborg University, 9220 Aalborg, Denmark.

Franco Molteni (F)

Villa Beretta Rehabilitation Center, Valduce Hospital Como, 23845 Costa Masnaga, Italy.

Lorenza Putignani (L)

Unit of Microbiomics and Research Unit of Human Microbiome, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.

Classifications MeSH